Authorization

E-cigarette company Juul is now doing health research, but its first study could bring more questions than answers

E-cigarette company Juul is now doing health research, but its first study could bring more questions than answers
Sarah Johnson/Flickr



On Saturday, for the first time in its roughly two-year history, e-cigarette company Juul presented some data from a clinical trial of its devices.




The company has a reputation for aggressively marketing its dessert-flavored nicotine products to teens, some of whom, research suggests, may now be at a higher risk of using regular cigarettes.




But Juul, which is now partially owned by Marlboro maker Altria, is now conducting scientific research.




In general, that research is considered a key step toward ensuring that a new product is not causing undo harm to people.




But the study still leaves many unanswered questions about the overall health of vaping, and also leaves unaddressed the issue of use by teens.



Juul, a Silicon Valley e-cigarette startup with a reputation for aggressively marketing its dessert-flavored nicotine products to teens, is now doing health research.
On Saturday the company, which is now partially owned by Marlboro maker Altria, presented a poster summary of a clinical trial comparing people who exclusively used its devices against people who smoked traditional cigarettes at an annual meeting for the Society for Research on Nicotine and Tobacco.
The study, sponsored by Juul and looking only at people who used its devices in isolation for five days (rather than switching back and forth between traditional cigarettes and e-cigs, as earlier research indicated most people do), is the first clinical trial the company has shared with members of the public. The full study has not been made public.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Май 2019    »
ПнВтСрЧтПтСбВс
 12345
6789101112
13141516171819
20212223242526
2728293031